High blood lipids can quietly affect the metabolic health of dogs and cats Elevated cholesterol and triglycerides can quietly affect the metabolic health and quality of life of dogs and cats. Because the effects build up over time, the challenge for pet owners is how to support blood-lipid control in a way that is safe and appropriate for long-term use. Vietnam Food Joint Stock Company (VNF) approaches this need through a chitosan-based supplement designed to work in the digestive tract, aiming to support lipid control rather than replace medical care. Vietnam Food Joint Stock Company (VNF) uses chitosan to bind dietary fat in the gut In the digestive tract, chitosan can bind to fat and bile acids, forming a complex that is difficult to absorb and is excreted in the faeces, which in turn helps reduce the amount of cholesterol entering the blood. In ChitoPal-C, VNF applies this mechanism to support pet metabolic health:
It traps fat and limits its absorption through the intestine
It supports reductions in total cholesterol and LDL-cholesterol
It helps limit the adverse effects associated with elevated cholesterol Study results support chitosan for cholesterol control in dogs and cats In a 45-day trial in hyperlipidemic dogs, chitosan reduced triglycerides by 44%, total cholesterol by 40% and LDL-cholesterol by 56%. In hyperlipidemic cats, the corresponding reductions reached 37%, 36% and 63% (Mosallanejad, 2018; Mosallanejad, 2016).
ChitoPal-C comes in powder and capsule forms and is given before meals or mixed into food. The product supports blood-lipid control and does not replace medication, a therapeutic diet or the instructions of a veterinarian. As pet owners increasingly look for safe, long-term nutritional support, the chitosan-based approach of Vietnam Food Joint Stock Company (VNF) reflects a wider move toward science-backed metabolic health solutions in companion-animal nutrition.